Entero Healthcare revenue grows 29.6% to ₹6,591 crore in FY26
The company reported a 35.6% rise in annual profit to ₹146 crore, driven by a mix of organic expansion and acquisitions.
— 2 earlier stories on Entero Healthcare Solutions Ltd. →What's new
- FY26 revenue reached ₹6,591 crore, up 29.6%.
- Profit after tax climbed 35.6% to ₹146 crore.
- The board approved a small bolt-on acquisition of two surgical distribution firms for ₹9.21 crore.
Why this matters
These results confirm the company's ongoing growth trajectory through both organic and inorganic channels. The latest acquisition is immaterial to the company's ₹5,887 crore market cap, serving as a routine addition rather than a shift in strategy.
What we're watching
- Integration progress of the newly acquired surgical distribution firms.
- Sustainability of the 35.6% profit growth rate in the coming fiscal year.
- Any further M&A activity to expand the distribution footprint.
The full read
Entero Healthcare Solutions closed FY26 with consolidated revenue of ₹6,591 crore, a 29.6% increase over the previous year. Profit after tax rose 35.6% to ₹146 crore, reflecting the company's reliance on both organic growth and acquisitions.
It is a steady performance.
Alongside these financial results, the board approved the purchase of two surgical distribution firms for a total of ₹9.21 crore, an acquisition that remains entirely immaterial given the company's ₹5,887 crore market capitalization. The filing also contained standard procedural items, including director reappointments and ESOP grants, which provide no new tradeable information for the market.
Questions answered
- How did Entero Healthcare perform in FY26?
- The company reported consolidated revenue of ₹6,591 crore, representing a 29.6% increase. Profit after tax grew by 35.6% to reach ₹146 crore.
- What is the scale of the new acquisition?
- Entero is acquiring two surgical distribution firms for up to ₹9.21 crore. This is considered immaterial given the company's market capitalization of ₹5,887 crore.
- Are there other material updates in the filing?
- No. The filing includes routine board outcomes such as director reappointments and ESOP grants, which carry no price-sensitive impact.
Story so far
All notes on ENTERO →- 25 May 2026 · 9:13 PM IST Entero Healthcare revenue grows 29.6% to ₹6,591 crore in FY26
- today Entero Healthcare reports 30% revenue growth in FY26
- today Entero Healthcare grows revenue 29.6% to ₹6,591 crore in FY26